Calpain and cathepsins in the skeletal muscle of inflammatory myopathies

European Neurology

Volumn 37, Issue 3, 1997, Pages 176-181

  Kumamoto, Toshihide ^a   Ueyama, Hidetsugu ^a   Sugihara, Rie ^a   Kominami, Eiki ^b   Goll, Darrel E ^c   Tsuda, Tomiyasu ^a  

^a OITA UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

Dermatomyositis; Intracellular proteolysis; Muscle fiber degradation; Polymyositis; Protease

Indexed keywords

CALPAIN; CATHEPSIN; CATHEPSIN B; CATHEPSIN H; CATHEPSIN L;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATOMYOSITIS; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; MONONUCLEAR CELL; MUSCLE BIOPSY; POLYMYOSITIS; PRIORITY JOURNAL; SKELETAL MUSCLE;

ADULT; ATROPHY; BIOPSY; CALPAIN; CATHEPSIN B; CATHEPSINS; CYSTEINE ENDOPEPTIDASES; DERMATOMYOSITIS; ENDOPEPTIDASES; FEMALE; HUMANS; INFLAMMATION; LYSOSOMES; MALE; MIDDLE AGED; MUSCLE FIBERS; MUSCLE, SKELETAL; NECROSIS; POLYMYOSITIS;

EID: 0030939046     PISSN: 00143022     EISSN: 14219913     Source Type: Journal    
DOI: 10.1159/000117430     Document Type: Article

References (15)

1. Emslie-Smith AM. Arahata K, Engel AG: Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T-cell-mediated cytotoxicity in myopathies. Hum Pathol 1989:20:224-231.
2. Emslie-Smith AM. Engel AG: Microvascular changes in early and advanced dermatomyositis: A quantitative study. Ann Neurol 1990;27: 343-356.
3. Kissel JT. Halterman RK. Rantmohan KW. Mendell JR: The relationship of complement-mediated microvasculopathy to the histologic features and clinical duration of diseases in dermatomyositis. Arch Neurol 1991:48:26-30.
4. Dalakas MC: Immunopathogenesis of inflammatory myopathies. Ann Neurol 1995;37(S1): S74-S86.
5. Orimo S, Koga R, Goto K, Nakamura K, Arai M, Tamaki M, Sugita H, Nonaka I, Arahata K: Immunohistochemical analysis of perforin and granzyme A in inflammatory myopathies. Neuromuscul Disord 1994;4:219-226.
6. Katunuma N, Kominami E, Noda T, Isogai K: Lysosomal thiol proteinases and muscular dystrophy: in Ebashi S, Ozawa E (eds): Muscular Dystrophy: Biomedical Aspects. Tokyo, Japan Science Society Press, 1983, pp 247-256.
7. Reddy PA. Anandavalli TE. Anandaraj MPJS: Calcium-activated neutral proteases (milli-and micro-CANP) and endogenous CANP inhibitor of muscle in Duchenne muscular dystrophy (DMD). Clin Chim Acta 1986:160:281-288.
8. Kumamoto T, Ueyama H, Watanabe S, Yoshioka K, Miike T, Goll DE, Ando M, Tsuda T: Immunohistochemical study of calpain and its endogenous inhibitor in the skeletal muscle of muscular dystrophy. Acta Neuropathol (Berl) 1995:89:399-403.
9. Kumamoto T, Ueyama H, Watanabe S, Kominami E, Ando M: Muscle fiber degradation in distal myopathy with rimmed vacuoles. Acta Neuropathol (Berl) 1994;87:143-148.
10. Dubowitz V: Muscle Biopsy: A Practical Approach. London, Baillière. Tindall. 1985. pp 19-40.
11. Kashiwa HK. Atkinson WB: The applicability of a new Schiff base, glyoxal bis (2-hydroxy-anil). for cytochemical localization of ionic calcium. J Histochem Cytochem 1963:11:258-264.
12. 2+-dependent proteinases and their inhibitor in normal, fasted, and denervated rat skeletal muscle. Anal Rec 1992:232:60-77.
13. Kumamoto T, Ueyama H, Watanabe S, Murakami T, Araki S: Effect of denervation on overdevelopment of chloroquine-induced autophagic vacuoles in skeletal muscles. Muscle Nerve 1993:16:819-826.
14. Podack ER. Young JD-E, Cohn ZA: Isolation and biochemical and functional characterization of perforin I from cytolytic T-cell granules. Proc Natl Acad Sci USA 1985:82:8629-8633.
15. Young JD-E, Cohn ZA, Podack ER: The ninth component of complement and the pore-forming protein (perforin 1) from cytotoxic T cells: Structural, immunological, and functional similarities. Science 1986:233:184-190.